RVTY Revvity, Inc.
$166.60▲ +2.93%
Healthcare
Other
Volume 771.7K
Avg Volume (10D) 1.59M
Key Metrics & Fundamentals
Market Cap
$18.59B
P/E Ratio
79.7
Div Yield
0.17%
52W Range
81.22 - 169.06
% vs 50 MA
14.09%
% vs 200 MA
45.73%
RSI-14
69.2
MACD Histogram
-0.1400
Beta (1Y vs SPY)
1.16
Free Cash Flow
$180.87M
Gross Rev
$729.69M
Gross Profit
$416.87M
EBITDA
$166.90M
COGS
$312.82M
Operating Exp
$329.01M
Operating Income
$87.85M
EBIT
$87.85M
Pretax Income
$63.53M
Net Income
$51.82M
EPS (Diluted)
0.46
Price & Volume History
Loading chart…
Recent News

Envista Q3 Earnings Ahead: Product Innovation to Drive Growth
Zacks · Oct 28, 2026 9:27 AM ET

Charles River Laboratories (CRL) Earnings Expected to Grow: Should You Buy?
Zacks · Oct 28, 2026 9:00 AM ET

Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report?
Zacks · Oct 27, 2026 11:10 AM ET

Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks · Oct 27, 2026 9:00 AM ET

Henry Schein to Report Q3 Earnings: Here's What You Should Know
Zacks · Oct 27, 2026 8:21 AM ET

CareDx to Report Q3 Earnings: Transplant Testing Growth in Focus
Zacks · Oct 26, 2026 8:58 AM ET

ELV vs. RVTY: Which Stock Is the Better Value Option?
Zacks · Oct 23, 2026 10:40 AM ET

Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings
Zacks · Oct 23, 2026 7:19 AM ET

Revvity Launches Signals LabGistics to Coordinate Scientific Workflows
Zacks · Oct 22, 2026 9:34 AM ET

Align Technology to Report Q3 Earnings: What's in the Cards?
Zacks · Oct 22, 2026 8:08 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See RVTY's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.